Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
619 JPY | -2.67% | -3.28% | -47.18% |
Apr. 25 | JCR Pharmaceuticals Co., Ltd. Announces Management Changes, Effective as of June 26, 2024 | CI |
Mar. 21 | US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak | MT |
Business Summary
Number of employees: 879
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 51,082 | 100.0 % | 34,343 | 100.0 % | -32.77% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 51,082 | 100.0 % | 34,343 | 100.0 % | -32.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 45 | 03-03-31 |
Yutaka Honda
ADM | Chief Administrative Officer | - | - |
Yoshio Hiyama
BRD | Director/Board Member | - | 19-03-31 |
Mathias Schmidt
BRD | Director/Board Member | 56 | 20-05-31 |
Takashi Suetsuna
BRD | Director/Board Member | 75 | 16-05-31 |
Toru Ashida
BRD | Director/Board Member | 55 | 13-12-31 |
Masaki Sumiyoshi
HRO | Human Resources Officer | - | - |
Masaya Ichikawa
AUD | Comptroller/Controller/Auditor | - | - |
Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Philippe Fauchet
BRD | Director/Board Member | 65 | - |
Toru Ashida
BRD | Director/Board Member | 55 | 13-12-31 |
Director/Board Member | 71 | 15-05-31 | |
Takashi Suetsuna
BRD | Director/Board Member | 75 | 16-05-31 |
Yutaka Atomi
BRD | Director/Board Member | 79 | - |
Yuko Hayashi
BRD | Director/Board Member | 59 | 18-06-26 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 45 | 03-03-31 |
Mathias Schmidt
BRD | Director/Board Member | 56 | 20-05-31 |
Yoshio Hiyama
BRD | Director/Board Member | - | 19-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 129,686,308 | 68,693,394 ( 52.97 %) | 4,881,914 ( 3.764 %) | 52.97 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
4,585,900 | 3.54% | 23,750,560 $ | |
204,000 | 0.54% | 4,135,353 $ |
Company contact information
JCR Pharmaceuticals Co., Ltd.
3-19 Kasuga-cho
659-0021, Ashiya
+81 7 9732 8591
http://www.jcrpharm.co.jpSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.18% | 509M | |
+34.35% | 705B | |
+31.18% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.26% | 238B | |
-3.72% | 210B | |
+10.19% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- 4552 Stock
- Company JCR Pharmaceuticals Co., Ltd.